California NanoSystems Institute
Text Size: A A A A

Michael Jung, Ph.D.

Director, Bioscience Synthetic Chemistry
Professor, Chemistry and Biochemistry, Organic Chemistry
Member, Basic/Translational Research, Jonsson Comprehensive Cancer Center, California NanoSystems Institute
Adjunct Faculty, Molecular & Medical Pharmacology
Researcher, Chemical Biology, Organic, Synthesis

Ph.D., Columbia University, 1973
B.A., Rice University, 1969

Honors and Awards:
UCLA, UCLA Hanson-Dow Teaching Award
American Chemical Society, American Chemical Society Arthur C. Cope Scholar Award
Alfred P. Sloan Fellow
UCLA, UCLA Distinguished Teaching Award
UCLA, Inaugural UCLA Gold Shield Faculty Prize
Auspex Pharmaceutical Co., Inc., Auspex Horizon Award
Arthur C. Cope Scholar Award
Fulbright-Hays Senior Research Scholar
Camille and Henry Dreyfus Teacher-Scholar
Tokushima University, Fujii-Ohtsuka Professor
Glenn T. Seaborg Award
UCLA, UCLA McCoy Award

Academic Experience:
Academic Experience:
1973 - 1974 ETH, Zurich, NATO Postdoctoral Fellow

Contact Information:
Email Address:
Work Email Address:
Laboratory Address: Mol Sci Bldg 3210
Work Address: Mol Sci Bldg 3505A
Home Page:
Work Phone Number: 1 (310) 825-7954
Lab Number: 1 (310) 825-0549
Research Interests:

The majority of the research personnel in my group are currently engaged in three general fields of interest: the development of new synthetic methods, the total synthesis of biologically active natural products, and medicinal chemistry. We are pursuing the total synthesis of potent antiviral agents, e.g., modified nucleosides and betulinic acid derivatives, several promising antitumor agents, e.g., tedanolide and 13-deoxytedanolide, eleutherobin, dichlorolissoclimide, haterumaimide E, the auripyrones, and laurenediterpenol. The use of epoxide rearrangements in synthesis, e.g., the non-aldol aldol process, and others, is under investigation as well, especially for the synthesis of new antibiotics of the erythromycin class. We are also studying the use of various reactions (e.g., Diels-Alder reactions, bridged Robinson annulation, [3,3] rearrangements) for the synthesis of biologically active molecules, e.g., the acetylcholinesterase inhibitors, the arisugacins; the immunosuppressive agent brasilicardin A; the antibacterial agent mycosporulone; and multiple drug resistance reversing agents such as welwitindolinone C. In particular, we are developing the mixed Lewis acid system, 5-10:1 AlBr3:AlMe3, in a variety of reactions, e.g., cycloadditions, nucleophilic additions, etc. We are developing new processes for the efficient synthesis of various oxygenated steroids, e. g., the cardioactive compound ouabain and the antitumor compound, rhodexin A. We have several collaborative programs in medicinal chemistry, e.g., to prepare various naturally occurring oxidation products of arachidonic acids, the epoxy isoprostanes (which are involved in the onset of atherosclerosis); to develop a new method of delivering antibacterial agents to resistant bacterial strains; the preparation and testing of new selective binders for both the estrogen and the androgen receptors as anti-cancer agents; the synthesis of molecules which differentiate stem cells into osteoblasts; the preparation of molecules to bind to the Sortase-A binding pocket to determine the structure of this important medicinal target; small molecule inhibitors of the growth of various viruses; and agents to stop the growth of tuberculosis.

Additional Information:

Mike Jung received his Bachelor of Arts in 1969 from Rice University, doing research with Richard Turner, and then his PhD in 1973 from Columbia, where he worked with Gilbert Stork. After a one-year NATO postdoctoral fellowship with Albert Eschenmoser at the ETH in Zurich, he joined the faculty at UCLA in 1974. He has risen through the ranks at UCLA and is now a Distinguished Professor of Chemistry. He has served as a reviewer of proposals for various organizations, e.g., NSF, PRF, NIH Medicinal Chemistry Study Section, Research Corporation and others. He is on the Scientific Advisory Boards of several pharmaceutical firms and consults currently for more than 20 industrial laboratories in both the biotech and big pharma settings. Professor Jung is an authority on synthetic organic and medicinal chemistry and has more than 25 patents arising from both his consulting activities and his own research. His current interests include the easy preparation of hindered systems via both Diels-Alder reactions using a new mixed Lewis acid catalyst and via an unusual formal [3,3]-sigmatropic rearrangement. He has also pioneered the use of epoxide rearrangements in synthesis (e.g., the non-aldol aldol) and has investigated new types of gem-disubstituent effects in synthesis. He has published more than 250 articles in refereed journals and has given over 470 lectures on his research, including lectures in German and French. Finally one of his recent compounds is in Phase 1/2a clinical trials for the treatment of hormone refractory prostate cancer.

Selected Publications:

Refik Kayali, Jin-Mo Ku, Gregory Khitrov, Michael E. Jung, Olga Prikhodko, and Carmen Bertoni, Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy, Human Molecular Genetics, 2012, 1-14.
M. C. Wolf, A. N. Freiberg, T.-H. Zhang, Z. Akyol-Ataman, A. Grock, P. W. Hong, J. Li, N. F. Watson, A. Q. Fang, H. C. Aguilar, M. Porotto, A. N. Honko, R. Damoiseaux, J. P. Miller, S. E. Woodson, S. Chantasirivisal, V. Fontanes, O. A. Negrete, P. Krogstad, A. Dasgupta, A. Moscona, L. E. Hensley, S. P. Whenlan, K. F. Faull, M. R. Holbrook, M. E. Jung, and B. Lee, A Broad-spectrum Antiviral Targeting Entry of Enveloped Viruses, PNAS, 2010, 107, 3157-62.
Xu W, Cai X, Jung ME, Tang Y, Analysis of intact and dissected fungal polyketide synthase-nonribosomal peptide synthetase in vitro and in Saccharomyces cerevisiae, J Am Chem Soc, 2010, 132 (39), 13604-7.
Aghajan M, Jonai N, Flick K, Fu F, Luo M, Cai X, Ouni I, Pierce N, Tang X, Lomenick B, Damoiseaux R, Hao R, Del Moral PM, Verma R, Li Y, Li C, Houk KN, Jung ME, Zheng N, Huang L, Deshaies RJ, Kaiser P, Huang J, Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase, Nat Biotechnol, 2010, 28 (7), 738-42.
Heinz A, Jung MC, Duca L, Sippl W, Taddese S, Ihling C, Rusciani A, Jahreis G, Weiss AS, Neubert RH, Schmelzer CE, Degradation of tropoelastin by matrix metalloproteinases--cleavage site specificities and release of matrikines, FEBS J, 2010, 277 (8), 1939-56.
M. E. Jung and J. J. Chang, Enantiospecific Formal Total Synthesis of (+)-Fawcettimine, Org. Lett, 2010, 12 (13), 2962–5.
Jared S. Johnson, Vicente Meliton, Woo Kyun Kim, Kwang-Bok Lee, Jeffrey C. Wang, KhanhLinh Nguyen, Dongwon Yoo, Michael E. Jung, Elisa Atti, Sotirios Tetradis, Renata C. Pereira, Clara Magyar, Taya Nargizyan, Theodore J. Hahn, Francine Farouz, Scott Thies, and Farhad Parhami , Novel Osteogenic Oxysterols Induce Osteogenic and Inhibit Adipogenic Differentiation of Marrow Stromal Cells In Vitro and Stimulate Bone Formation and Spinal Fusion In Vivo, Journal of Cellular Biochemistry, 2010, 112 (6), 1673-84.
M. E. Jung, S. Ouk, D. Yoo, C. L. Sawyers, C. Chen, C. Tran, and J. Wongvipat, Structure-Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC), J. Med. Chem, 2010, 53 (7), 2779-96.
Jung ME, Lui RM, Studies toward the Total Syntheses of Cucurbitacins B and D, J Org Chem, 2010, 75 (21), 7146-58.
Jung ME, Zhang TH, Lui RM, Gutierrez O, Houk KN, Synthesis of a trans,syn,trans-dodecahydrophenanthrene via a bicyclic transannular Diels-Alder reaction: intermediate for the synthesis of fusidic acid, J Org Chem, 2010, 75 (20), 6933-40.
M. E. Jung, M. Chaumontet, and R. Salehi-Rad, Total Synthesis of Auripyrone B Using a Non-Aldol Aldol-Cuprate Opening Process, Org. Lett, 2010, 12 (12), 2872-5.
Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, Wongvipat J, Smith-Jones PM, Yoo D, Kwon A, Wasielewska T, Welsbie D, Chen CD, Higano CS, Beer TM, Hung DT, Scher HI, Jung ME, Sawyers CL , Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer , Science , 2009, 324 (5928), 787-790.
N. Suree, S. W. Yi, W. Thieu, M. Marohn, R. Damoiseaux, A. Chan, M. E. Jung and R. T. Clubb, Discovery and Structure Activity Relationship Analysis of Staphylococcus aureus Sortase A Inhibitors, Bioorg. Med. Chem, 2009, 17 (20), 7174-85.
L. Du, R. Damoiseaux, S. Nahas, J. Pollard, J. Goldstine, H. Hu, M. E. Jung, R. A. Gatti, Identification of compounds with the ability to induce readthrough of nonsense mutations, J. Experimental Med, 2009, 206 (10), 2285-2297.
N. Suree, C. K. Liew, V. Villareal, W. Thieu, E. A. Fadeev, J. J. Clemens, M. E. Jung and R. T. Clubb, Structure of the Staphylococcus aureus SrtA sortase covalently bound to a LPXTG sorting signal, J. Biol. Chem, 2009, 284 (36), 24465-77.
Jung, M. E. Perez, F., Synthesis of 2-substituted 7-hydroxybenzofuran-4-carboxylates via addition of silyl enol ethers to o-benzoquinone esters, Org Lett, 2009, 11 (10), 2165-7.
M. E. Jung and G-Y. Im, The Total Synthesis of Racemic Laurenditerpenol, an HIF-1 Inhibitor, J. Org. Chem, 2009, 74 (22), 8739–53.
M. E. Jung, J. Cordova, and M. Murakami, Total Synthesis of (±)-Kellermanoldione: Stepwise Cycloaddition of a Functionalized Diene and Allenoate, Org. Lett, 2009, 11 (17), 3882-3885.
M. E. Jung and R. Salehi-Rad, Total Synthesis of Auripyrone A Using a Tandem Non-Aldol Aldol-Paterson Aldol Process as a Key Step, Angew Chem Int Ed Engl, 2009, 48 (46), 8766-9.
Jung, M. E. Allen, D. A., Use of 4-cyanocoumarins as dienophiles in a facile synthesis of highly substituted dibenzopyranones, Org Lett, 2009, 11 (3), 757-60.
M. E. Jung and G-Y. Im, Convergent Total Synthesis of the Racemic HIF-1 Inhibitor Laurenditerpenol, Tetrahedron Lett, 2008, 49 (33), 4962-4964.
M. E. Jung and D. A. Allen, Facile Synthesis of syn 2-Alkyl-3-trialkylsilyloxycycloalkanones via the First Non-Aldol Aldol Process of 2,3-Epoxycycloalkanols, Org. Lett, 2008, 10 (10), 2039-2041.
W. Zhang, K. Watanabe, X. Cai, M. E. Jung, Y. Tang, and J. Zhan, Identifying the Minimal Enzymes Required for Anhydrotetracycline Biosynthesis, J. Am. Chem. Soc, 2008, 130 (19), 6068-6069.
M. E. Jung, J. A. Berliner, L. Koroniak, A. D. Watson, and B. G. Gugiu, Improved Synthesis of the Epoxy Isoprostane Phospholipid PEIPC and its Reactivity with Amines, Org. Lett, 2008, 10 (19), 4207-4209.
M. E. Jung and T.-H. Zhang, New Protocol for Anti-Selective Aldol Condensation of Ethyl Ketones with α-Alkoxyaldehydes, Org. Lett, 2008, 10 (1), 137-40.
M. E. Jung and H. V. Chu, Preparation of a Functionalized Tetracyclic Intermediate for the Synthesis of Rhodexin A, Org. Lett, 2008, 10, 3647-3649.
M. E. Jung and D. Yoo, Synthesis of the C1 -C12 Fragment of the Tedanolides. Selective Hydroboration-protonation of Allylic Alcohol Approach, Tetrahedron Lett, 2008, 49 (5), 816-819.
M. C. Duncan, D. G. Ho, J. Huang, M. E. Jung, and G. S. Payne, Composite Synthetic Lethal Identification of Membrane Traffic Inhibitors, Proc. Natl. Acad. Sci. U. S. A, 2007, 104 (15), 6235-6240.
M. C. Duncan, D. G. Ho, J. Huang, M. E. Jung, and G. S. Payne, Compound Synthetic Lethal Identification Membrane Traffic Inhibitors, PNAS, 2007, 104 (15), 6235-6240.
M. E. Jung and J. M. Murphy, Functional Group Selectivity in Reactions of Epoxides with Tungsten Hexachloride, Tetrahedron Lett, 2007, 48 (47), 8388-8391.
N. Suree, M. E. Jung, and R. T. Clubb, Recent Advances Towards New Anti-infective Agents that Inhibit Cell Surface Protein Anchoring in Staphylococcus aureus and Other Gram-positive Pathogens, Mini Reviews in Medicinal Chemistry, 2007, 7 (10), 991-1000.
J. M. Tsay, M. Trzoss, L. Shi, X. Kong, M. Selke, M. E. Jung, and S. Weiss, Singlet Oxygen Production by Peptide-Coated Quantum Dot-Photosensitizer Conjugates, J. Am. Chem. Soc, 2007, 129 (21), 6865-6871.
M. E. Jung and D. Ho, Stepwise Acid-Promoted Double-Michael Process: an Alternative to Diels-Alder Cycloadditions for Hindered Silyloxydiene-Dienophile Pairs, Org. Lett, 2007, 9 (2), 375-378.
M. E. Jung and D. Yoo, Synthesis of the C1 -C12 Fragment of the Tedanolides. Aldol-Non-Aldol Aldol Approach, Org. Lett, 2007, 9, 3543-3546.
M. E. Jung and S.-J. Min, Synthetic Approaches to the Synthesis of Arisugacin A, Tetrahedron, 2007, 63 (18), 3682-3701.
M. E. Jung and M. Murakami, Total Synthesis of (+/-)-Hedychilactone B: Stepwise Allenoate Diene Cycloaddition to Prepare Trimethyldecalin Systems, Org. Lett, 2007, 9 (3), 461-463.
M. E. Jung and D. Yoo, Unprecedented Rearrangement of a 4-Alkoxy-5-bromoalk-2-en-1-ol to a Cyclopentenone via an Iso-Nazarov Cyclization Process, J. Org. Chem, 2007, 72 (22), 8565-8568.
M. T. Naik, N. Suree, N. U. Ilangovan, C. K. Liew, J. Clemens, M. E. Jung, and R. T. Clubb, A Calcium Modulated Loop Closure Mechanism Activates Cell Surface Protein Anchoring by the Staphylococcus aureus Sortase A Transpeptidase, J. Biol. Chem, 2006, 281, 1817-1826.
M. E. Jung and W.-J. Kim, Practical Syntheses of Dyes for Difference Gel Electrophoresis (DIGE), Bioorg. Med. Chem, 2006, 14 (1), 92-97.
M. E. Jung and B. A. Duclos, Synthetic Approach to Analogues of Betulinic Acid, Tetrahedron, 2006, 62 (40), 9321-9334.
Y.-L. Zhao, C. P. Suhrada, M. E. Jung and K. N. Houk, The 3-Vinylmethylenecyclo-butane-4-Methylenecyclohexene Rearrangement: Theoretical Investigation of a Stereo-selective Stepwise Cope Rearrangement, J. Am. Chem. Soc, 2006, 128 (34), 11106-11113.
M. E. Jung and M. Murakami, Total Synthesis of (+/-)-Hedychenone: Trimethyldecalin Terpenes via Stepwise Allenoate Diene Cycloaddition, Org. Lett, 2006, 8 (25), 5857-59.
Y. Akiba, M. E. Jung, S. Ouk, and J. D. Kaunitz, A Novel Small Molecule CFTR Inhibitor Attenuates HCO3- Secretion And Duodenal Ulcer Formation In Rats, Amer. J. Physiol. GI Liver Physiol, 2005, 289 (4), G753-G759.
M. E. Jung and A. R. Novack, Formation of 3,4-Dimethyl-2-pyrones from Allene Carboxylates and 2-Silyloxydienes via 3-Carboethoxyethylidene Cyclobutanols, Tetrahedron Lett, 2005, 46 (47), 8237-8240.
M. E. Jung and G. Piizzi, Gem-Disubstituent Effect: Theoretical Basis and Synthetic Applications, Chem Rev, 2005, 105 (5), 1735-1766.
M. E. Jung and S.-J. Min, Intramolecular Diels-Alder Reactions of Optically Active Allenic Ketones: Chirality Transfer in the Preparation of Substituted Oxa-bridged Octalones, J. Am. Chem. Soc, 2005, 127 (31), 10834-5.
M. E. Jung, J. J. Clemens, N. Suttee, C. K. Liew, and R. T. Clubb, Synthesis of (2R, 3S) 3-Amino-4-mercapto-2-butanol, a Threonine Analogue for Covalent Inhibition of Sortases, Bioorg. Med. Chem. Letts, 2005, 15 (22), 5076-5079.
Jung, M. E. Ho, D. Chu, H. V., Synthesis of highly substituted cyclohexenes via mixed Lewis acid-catalyzed Diels-Alder reactions of highly substituted dienes and dienophiles, Org Lett, 2005, 7 (8), 1649-51.
M. E. Jung and A. Maderna, Synthesis of Bicyclo[2.2.2]oct-5-en-2-ones via a Tandem Intermolecular Michael Addition Intramolecular Aldol Process (a Bridged Robinson Annulation), Tetrahedron Lett, 2005, 46 (30), 5057-5061.
Jung, M. E. Berliner, J. A. Angst, D. Yue, D. Koroniak, L. Watson, A. D. Li, R., Total synthesis of the epoxy isoprostane phospholipids PEIPC and PECPC, Org Lett, 2005, 7 (18), 3933-5.
Jung, M. E. Nishimura, N. Novack, A. R., Versatile diastereoselectivity in formal [3,3]-sigmatropic shifts of substituted 1-alkenyl-3-alkylidenecyclobutanols and their silyl ethers, J Am Chem Soc, 2005, 127 (32), 11206-7.
J. E. Katz, D. S. Dumlao, J. I. Wasserman, M. G. Lansdown, M. E. Jung, K. F. Faull and S. Clarke, 3-Isopropylmalate is the Major Endogenous Substrate of the Saccharomyces cerevisiae trans-Aconitate Methyltransferase, Biochemistry, 2004, 43 (20), 5976-86.
M. E. Jung and A. Maderna, Allylation of Acetals and Ketals with Allyltrimethylsilane Catalyzed by the Mixed Lewis Acid System AlBr3/CuBr, Tetrahedron Lett, 2004, 45, 5301-04.
M. E. Jung and B. A. Duclos, Diastereoselectivity in the Carroll Rearrangement of β-Keto Esters of Tertiary Allylic Alcohols, Tetrahedron Lett, 2004, 45 (1), 107-9.
C. K. Liew, B. T. Smith, R. Pilpa, U. Ilangovan, K. M. Connolly, M. E. Jung, and R. T. Clubb, Localization and mutagenesis of the sorting signal binding site on sortase A from Staphylococcus aureus, FEBS Lett, 2004, 571 (1-3), 221-226.
Jung, M. E. Maderna, A., Microwave-assisted allylation of acetals with allyltrimethylsilane in the presence of CuBr, J Org Chem, 2004, 69 (22), 7755-7.
M. E. Jung and S.-J. Min, Novel Formation of a Bridged Bicyclic Furan by Rearrangement of a Tetrahydroxydecalinone, Tetrahedron Lett, 2004, 45, 6753-6755.
Jung, M. E. Min, S. J. Houk, K. N. Ess, D., Synthesis and relative stability of 3,5-diacyl-4,5-dihydro-1H-pyrazoles prepared by dipolar cycloaddition of enones and alpha-diazoketones, J Org Chem, 2004, 69 (26), 9085-9.
Jung, M. E. van den Heuvel, A., A tandem non-aldol aldol Mukaiyama aldol reaction, Org Lett, 2003, 5 (24), 4705-7.
M. E. Jung and J. I. Wasserman, Efficient Synthesis of Vinyl Chlorides and/or gem-Dichlorides from Ketones by Treatment with Tungsten Hexachloride, Tetrahedron Lett, 2003, 44 (39), 7273-75.
Jung, M. E. Piizzi, G., First synthesis of the A/B ring of ouabain, Org Lett, 2003, 5 (2), 137-40.
Connolly, K. M. Smith, B. T. Pilpa, R. Ilangovan, U. Jung, M. E. Clubb, R. T., Sortase from Staphylococcus aureus does not contain a thiolate-imidazolium ion pair in its active site, J Biol Chem, 2003, 278 (36), 34061-5.
Jung, M. E. Kers, A. Subbanagounder, G. Berliner, J. A., Studies towards the total synthesis of an epoxy isoprostane phospholipid, a potent activator of endothelial cells, Chem Commun (Camb), 2003, 2, 196-7.
Jung, M. Voit, S. Klimek, J., Surface geometry of three packable and one hybrid composite after finishing, Oper Dent, 2003, 28 (1), 53-9.
Y. Nagao, C. Kimura, K. Kozawa, and M. E. Jung, Synthesis, Stereochemistry, and Reactions of 2,5-Diphenylsilacyclopentenes, Silicon Chem, 2003, 2 (1-2), 99-107.
M. E. Jung and J. Pontillo, Synthetic Approach to Analogues of Sclerophytin A, Tetrahedron, 2003, 59 (15), 2729-2736.
Jung, M. E. Piizzi, G., Synthetic approach to the AB ring system of ouabain, J Org Chem, 2003, 68 (7), 2572-82.
Leach, A. G. Wang, R. Wohlhieter, G. E. Khan, S. I. Jung, M. E. Houk, K. N., Theoretical elucidation of kinetic and thermodynamic control of radical addition regioselectivity, J Am Chem Soc, 2003, 125 (14), 4271-8.
Jung, M. E. van den Heuvel, A. Leach, A. G. Houk, K. N., Unexpected syn hydride migration in the non-aldol aldol reaction, Org Lett, 2003, 5 (19), 3375-8.
Jung, M. E. Hoffmann, B. Rausch, B. Contreras, J. M., Use of hindered silyl ethers as protecting groups for the non-aldol aldol process, Org Lett, 2003, 5 (17), 3159-61.
M. E. Jung and A. van den Heuvel, Diastereoselectivity in non-Aldol Aldol Reactions: Silyl Triflate Promoted Payne Rearrangements, Tetrahedron Lett, 2002, 43 (45), 8169-8172.
Jung, M. E. Davidov, P., Efficient synthesis of a tricyclic BCD analogue of ouabain: Lewis acid catalyzed Diels-Alder reactions of sterically hindered systems, Angew Chem Int Ed Engl, 2002, 41 (21), 4125-8.
Jung, M. E. Piizzi, G., Novel rearrangements of 4-silyl-3-buten-2-ones, J Org Chem, 2002, 67 (11), 3911-4.
M. E. Jung, A. Toyota, E. De Clercq, and J. Balzarini, Synthesis and Biological Activity of a Series of Methylene-Expanded Oxetanocin Nucleoside Analogues, Monatshefte Chem, 2002, 133 (4), 499-520.
Jung, M. E. Pontillo, J., Synthetic approach to analogues of the original structure of sclerophytin A, J Org Chem, 2002, 67 (19), 6848-51.
Jung, M. E. Nishimura, N., Enantioselective formal total synthesis of (-)-dysidiolide, Org Lett, 2001, 3 (13), 2113-5.